fever and neutropenia
Fever and neutropenia in the pediatric patient, a different perspective between latin america and europe
6
Fluconazole for empiric antifungal therapy in cancer patients with fever and neutropenia
10
External Validation of Six Pediatric Fever and Neutropenia Clinical Decision Rules
32
Assessment of procalcitonin as a diagnostic marker of infection in pediatrics with cancer complicated by fever and neutropenia
8
Interventions aiming to reduce time to antibiotics (TTA) in patients with fever and neutropenia during chemotherapy for cancer (FN), a systematic review
13
Successful adaptation of fever and neutropenia clinical practice guideline in China
5
Performance of Interleukin 6 and Interleukin 8 serum levels in pediatric oncology patients with neutropenia and fever for the assessment of low risk
7
Improving Timeliness of Antibiotic Delivery for Patients With Fever and Suspected Neutropenia in a Pediatric Emergency Department
12
Bacterial rRNA Targeted Reverse Transcription PCR Used To Identify Pathogens Responsible for Fever with Neutropenia
5
Protocol for a systematic review of time to antibiotics (TTA) in patients with fever and neutropenia during chemotherapy for cancer (FN) and interventions aiming to reduce TTA
10
Protocol for a systematic review of time to antibiotics (TTA) in patients with fever and neutropenia during chemotherapy for cancer (FN) and interventions aiming to reduce TTA
11
Risk Factors for Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation : A Systematic Review
20
Fusarium proliferatum Soft Tissue Infection at the Site of a Puncture by a Plant: Recovery, Isolation, and Direct Molecular Identification
5
Predicting Infectious ComplicatioNs in Children with Cancer : An external validation study
9
Updated systematic review and meta-analysis of the predictive value of serum biomarkers in the assessment and management of fever during neutropenia in children with cancer
13
CYCLIC NEUTROPENIA IN AN INFANT
11
Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis
5
Utility of blood procalcitonin concentration in the management of cancer patients with infections
7
Correction of Neutropenia Associated With Dysgammaglobulinemia
6
A clinical and molecular review of ubiquitous glucose-6-phosphatase deficiency caused by G6PC3mutations
17